Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
1.689B
Cash
520.7M
Avg Qtr Burn
-42.79M
Short % of Float
20.91%
Insider Ownership
11.37%
Institutional Own.
-
Qtr Updated
12/31/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Phase 2 Data readout | ||
APG777 Details Asthma | Phase 2 Initiation | |
APG808 Details Allergic diseases Type 2, Chronic obstructive pulmonary disease, Asthma | Phase 1b Data readout | |
APG279 (APG777 + APG990) Details Atopic Dermatitis (AD) | Phase 1b Initiation | |
APG990 Details Atopic dermatitis | Phase 1 Data readout | |
APG333 Details Asthma, Chronic obstructive pulmonary disease | Phase 1 Data readout |